Lymphoma and MM Flashcards
what is lymphoma
group of lymphoproliferative disorders originating in lymphocytes/ lymphatic tissue
what is the defining feature of hodgkin’s lymphoma
reed-sternbery cell
describe hodgkin’s lymphoma
B cell only, aggressive
3RF for hodgkin’s lymphoma
prolonged EBV infection, family Hx, (siblings of same sex), HIV
nonhodgkin’s lymphoma RFs
HIV, FHx (first degree), EBC, H pylori, MALD, burkitt, weakened immune sx, autoimmune disease
types of NHL
B (DLBCL), T, or NK/T cell
can be indolent or aggressive
diagnosis of B cell lymphoma rquires
Excisional lymph node biopsy of preferably largest regionally involved lymph node
For extranodal lymphomas = use sizable biopsy from organ of origin
Fine needle biopsy inadequate for initial diagnosis
when the excised lymph node is examined by the pathologist, what will they look for?
phenotyping- CD20 on B cells
gene rearrangements
EBV
what additional workup may be done for lymphomas besides lymph node examination
CT/PET
IPI score
lab chemistries
testing for comorbidities- pregnancy, HIV, EBV, hep B, pulmonary and ECHO/MUGA test if bleomycin or anthracyclines
stage of lymphoma if Single lymph node region (I) or one extralymphatic organ
1
stage of lymphoma if local extralymphatic extension plus lymph nodes, same side of diaphragm
2
stage of lymphoma if 2 or more lymph node regions, same side of diaphragm
2E
stage of lymphoma if local extra lymph extensions
3E
stage of lymphoma if lymph node regions on both sides of the diaphragm either alone
3
stage of lymphoma if Diffuse involvement of one or more extralymphatic organs or sites
4A (if no B sx)
stage of lymphoma if Diffuse involvement of one or more extralymphatic organs or sites with unexplained weight loss >10% from baseline within 6 mths of staging, unexpected fever >38C, or drenching night sweats
4B
list the 3 B sx
unexplained weight loss >10% from baseline in 6mths
unexpected fever >38C
drenching night sweats
what is treatment for DLBCL
RCHOP
rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone
rituximab 3 sus MOA
binds CD20 and cells die either by being recognized by effector cells, complement activation, or direct cell death
most common rituximab AE + what to do to prevent it
infusion reaction
premedicate with acetaminophen, diphenhydramine or loratidine, hydrocortisone, ranitidine or famotidine
hold ACEi/ARBs 24hrs pre
how should rituximab therapy be initiated
first dose should always be given IV, if no AEs, next dose can be given SQ
if first dose was not complete due to AEs, must have one full IV dose before SQ possible
what is the difference between IV and SQ rituximab
IV is dosed by 375mg/m2, SQ is a fixed flat dose of 1400mg
cyclophosphamide AEs
hemorrhagic cystisis
N/V- HEC with doxorubicin in RCHOP
myelosuppression, alopecia, fertility suppression
cyclophosphamide MOA
Alkylating agent- nitrogen mustard type: binds to DNA + cross links DNA and RNA = no protein synthesis
doxorubicin MOA
Anthracycline: inhib TP2 and prevents relegation of DNA during replication
Damages DNA and cell membranes by producing free radicals
doxorubicin AEs
cardiotoxicity
- late onset: reduced LVEF or CHF (more common)
- early onset: acute transient ECG changes to arrhythmia
myelosuupression
HEC with cyclophosphamide in RCHOP
alopecia
discoloration of urine
what must be done before initiating doxorubicin in RCHOP
ECHO or MUGA- LVEF must be =>50%
vincristine MOA
Vinca alkaloid - binds to tubulin (protein on spindle) and prevents mitosis
IV admin only (fatal if intrathecal)
vincristine AEs
Neurotoxicity
Peripheral neuropathy
Autonomic neuropathy- constipation (may require stool softeners and laxatives prophylactically)
what to monitor for prednisone in RCHOP
blood glucose- diabetics esp
mood changes
insomnia- may require zopiclone on prednisone days
GERD- take with food
what is included in supportive care for RCHOP
antinauseants
infection prevention (entecavir or tenofovir for HepB prophylxis)
prophylaxis for tumor lysis syndrome
factors reducing chances of cure in hodgkin’s lymphoma
Stage IV, ≥3 extranodal sites
Age ≥45yrs old
Male gender
Albumin <40
High WBC count (≥15)
Lymphocytopenia (lymphocytes <8% or <0.6%)
Hg <105
factors that reduce ability to tolerate intense chemo in hodgkin’s
≥60yrs old
ECOG >2
HIV +
2 treatments for hodgkin’s
Esc-BEACOOP
ABVD